Detalhe da pesquisa
1.
Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34.
Breast Cancer Res Treat
; 200(1): 151-162, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37199805
2.
The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling.
Int J Mol Sci
; 24(24)2023 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38139260
3.
SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance.
Breast Cancer Res
; 24(1): 26, 2022 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35395812
4.
Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Stem Cells
; 39(5): 536-550, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33470499
5.
FASN inhibition as a potential treatment for endocrine-resistant breast cancer.
Breast Cancer Res Treat
; 187(2): 375-386, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33893909
6.
KDM1A inhibition is effective in reducing stemness and treating triple negative breast cancer.
Breast Cancer Res Treat
; 185(2): 343-357, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33057995
7.
PELP1 signaling contributes to medulloblastoma progression by regulating the NF-κB pathway.
Mol Carcinog
; 59(3): 281-292, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872914
8.
Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers.
Breast Cancer Res
; 21(1): 150, 2019 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-31878959
9.
NADPH oxidase 4 induces cardiac fibrosis and hypertrophy through activating Akt/mTOR and NFκB signaling pathways.
Circulation
; 131(7): 643-55, 2015 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-25589557
10.
Activation of AMP-activated protein kinase prevents TGF-ß1-induced epithelial-mesenchymal transition and myofibroblast activation.
Am J Pathol
; 185(8): 2168-80, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26071397
11.
Novel LIPA-Targeted Therapy for Treating Ovarian Cancer.
Cancers (Basel)
; 16(3)2024 Jan 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38339252
12.
Preclinical Development of Brain Permeable ERß Agonist for the Treatment of Glioblastoma.
Mol Cancer Ther
; 22(11): 1248-1260, 2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37493258
13.
PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis.
Mol Oncol
; 2023 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37853941
14.
Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma.
Neuro Oncol
; 25(7): 1249-1261, 2023 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36652263
15.
Pharmacological inhibition of KDM1A/LSD1 enhances estrogen receptor beta-mediated tumor suppression in ovarian cancer.
Cancer Lett
; 575: 216383, 2023 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37714256
16.
Targeting LIF/LIFR signaling in cancer.
Genes Dis
; 9(4): 973-980, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35685476
17.
Global Genomic and Proteomic Analysis Identified Critical Pathways Modulated by Proto-Oncogene PELP1 in TNBC.
Cancers (Basel)
; 14(4)2022 Feb 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35205680
18.
The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events.
Cancer Lett
; 540: 215717, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35568265
19.
KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer.
Cancer Lett
; 524: 219-231, 2022 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34673129
20.
Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth.
Cancers (Basel)
; 14(21)2022 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36358818